Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survival

British Journal of Haematology

Volumn 123, Issue 5, 2003, Pages 869-878

  Burger, Renate ^a   Bakker, Frank ^b   Guenther, Andreas ^b   Baum, Wolfgang ^b   Schmidt Arras, Dirk ^b   Hideshima, Teru ^a   Tai, Yu Tzu ^a   Shringarpure, Reshma ^a   Catley, Laurence ^a   Senaldi, Giorgio ^c   Gramatzki, Martin ^b   Anderson, Kenneth C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c AMGEN INC   (United States)

Author keywords

Cardiotrophin like cytokine; gp130; Multiple myeloma; Novel neurotrophin 1 B cell stimulating factor 3; Signal transducer and activator of transcription 3

Indexed keywords

B CELL STIMULATING FACTOR 3; CARDIOTROPHIN LIKE CYTOKINE; CYTOKINE; GLYCOPROTEIN GP 130; GLYCOPROTEIN GP 130 ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 3; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; NEUROTROPHIN; NEUTRALIZING ANTIBODY; NOVEL NEUROTROPHIN 1; PROTEIN P44; RECOMBINANT CYTOKINE; STAT3 PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CELL GROWTH; CELL PROTECTION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE ACTIVATION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MULTIGENE FAMILY; MYELOMA; MYELOMA CELL; PATHOPHYSIOLOGY; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DIVISION; CYTOKINE RECEPTOR GP130; CYTOKINES; DEXAMETHASONE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; MEMBRANE GLYCOPROTEINS; MULTIPLE MYELOMA; PHOSPHORYLATION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TYRPHOSTINS;

EID: 10744227618     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2003.04686.x     Document Type: Article

References (35)

1. Alas, S. & Bonavida, B. (2003) Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis. Clinical Cancer Research, 9, 316-326.
2. Burger, R., Neipel, F., Fleckenstein, B., Savino, R., Ciliberto, G., Kalden, J.R. & Gramatzki, M. (1998) Human herpesvirus type 8 (HHV-8) interleukin-6 homologue is functionally active on human myeloma cells. Blood, 91, 1858-1863.
3. Burger, R., Guenther, A., Bakker, F., Schmalzing, M., Bernand, S., Baum, W., Duerr, B., Hocke, G.M., Steininger, H., Gebhart, E. & Gramatzki, M. (2001) Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma. The Hematology Journal, 2, 42-53.
4. Catlett-Falcone, R., Landowski, T.H., Oshiro, M.M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernandez-Luna, J.L., Nunez, G., Dalton, W.S. & Jove, R. (1999) Constitutive activation of Stat3 signalling confers resistance to apoptosis in human U266 myeloma cells. Immunity, 10, 105-115.
5. Chauhan, D., Pandey, P., Hideshima, T., Treon, S., Raje, N., Davies, F.E., Shima, Y., Tai, Y.T., Rosen, S., Avraham, S., Kharbanda, S. & Anderson, K.C. (2000) SHP2 mediates the protective effect of interleukin-6 against dexamethasone-induced apoptosis in multiple myeloma cells. Journal of Biological Chemistry, 275, 27845-27850.
6. Chevalier, S., Fourcin, M., Robledo, O., Wijdenes, J., Pouplard-Barthelaix, A. & Gascan, H. (1996) Interleukin-6 family of cytokines induced activation of different functional sites expressed by the gp130 transducing protein. Journal of Biological Chemistry, 271, 14764-14772.
7. Davis, S., Aldrich, T.H., Valenzuela, D.M., Wong, V.V., Furth, M.E., Squinto, S.P. & Yancopoulos, G.D. (1991) The receptor for ciliary neurotrophic factor. Science, 253, 59-63.
8. De Vos, J., Jourdan, M., Tarte, K., Jasmin, C. & Klein, B. (2000) JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells. British Journal of Haematology, 109, 823-828.
9. Elson, G.C., Lelièvre, E., Guillet, C., Chevalier, S., Plun-Favreau, H., Froger, J., Suard, I., de Coignac, A.B., Delneste, Y., Bonnefoy, J.Y., Gauchat, J.F. & Gascan, H. (2000) CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex. Nature Neuroscience, 3, 867-872.
10. Fattori, E., Della Rocca, C., Costa, P., Giorgio, M., Dente, B., Pozzi, L. & Ciliberto, G. (1994) Development of progressive kidney damage and myeloma kidney in interleukin-6 transgenic mice. Blood, 83, 2570-2579.
11. Fukada, T., Hibi, M., Yamanaka, Y., Takahashi-Tezuka, M., Fujitani, Y., Yamaguchi, T., Nakajima, K. & Hirano, T. (1996) Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity, 5, 449-460.
12. Hallek, M., Bergsagel, P.L. & Anderson, K.C. (1998) Multiple myeloma: increasing evidence for a multistep transformation procees. Blood, 91, 3-21.
13. Hardin, J., MacLeod, S., Grigorieva, I., Chang, R., Barlogie, B., Xiao, H. & Epstein, J. (1994) Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood, 84, 3063-3070.
14. Heath, J.K. & Bravo, J. (2000) Receptor recognition by gp130 cytokines. EMBO Journal, 19, 2399-2411.
15. Heinrich, P.C., Behrmann, I., Müller-Newen, G., Schaper, F. & Graeve, L. (1998) Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochemical Journal, 334, 297-314.
16. Heymann, D. & Rousselle, A.V. (2000) Gp130 cytokine family and bone cells. Cytokine, 12, 1455-1468.
17. Hideshima, T. & Anderson, K.C. (2002) Molecular mechanisms of novel therapeutic approaches for multiple myeloma. Nature Reviews Cancer, 2, 927-937.
18. Hideshima, T., Nakamura, N., Chauhan, D. & Anderson, K.C. (2001) Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene, 20, 5991-6000.
19. Juge-Morineau, N., Francois, S., Puthier, D., Godard, A., Bataille, R. & Amiot, M. (1995) The gp 130 family cytokines IL-6, LIF and OSM but not IL-11 can reverse the anti-proliferative effect of dexamethasone on human myeloma cells. British Journal of Haematology, 90, 707-710.
20. Kishimoto, T., Akira, S., Narazaki, M. & Taga, T. (1995) Interleukin-6 family of cytokines and gp130. Blood, 86, 1243-1254.
21. Klein, B., Zhang, X.G., Lu, Z.Y. & Bataille, R. (1995) Interleukin-6 in human multiple myeloma. Blood, 85, 863-872.
22. Lelièvre, E., Plun-Favreau, H., Chevalier, S., Froger, J., Guillet, C., Elson, G.C.A., Gauchat, J. & Gascan, H. (2001) Signaling pathways recruited by the cardiotrophin-like cytokine/cytokine-like factor-1 composite cytokine. Journal of Biological Chemistry, 276, 22476-22484.
23. Lichtenstein, A., Tu, Y., Fady, C., Vescio, R. & Berenson, J. (1995) Interleukin-6 inhibits apoptosis of malignant plasma cells. Cellular Immunology, 162, 248-255.
24. Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J.S., Freedman, M., Cohen, A., Gazit, A., Levitzki, A. & Roifman, C.M. (1996) Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature, 379, 645-648.
25. Nishimoto, N., Ogata, A., Shima, Y., Tani, Y., Ogawa, H., Nakagawa, M., Sugiyama, H., Yoshizaki, K. & Kishimoto, T. (1994) Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130. Journal of Experimental Medicine, 179, 1343-1347.
26. Plun-Favreau, H., Elson, G., Chabbert, M., Froger, J., deLapeyriere, O., Lelièvre, E., Guillet, C., Hermann, J., Gauchat, J.F., Gascan, H. & Chevalier, S. (2001) The ciliary neurotrophic factor receptor α component induces the secretion of and is required for functional responses to cardiotrophin-like cytokine. EMBO Journal, 20, 1692-1703.
27. Puthier, D., Bataille, R. & Amiot, M. (1999) IL-6 up-regulates Mcl-1 in human myeloma cells through JAK/STAT rather than Ras/ MAP kinase pathway. European Journal of Immunology, 29, 3945-3950.
28. Senaldi, G., Varnum, B.C., Sarmiento, U., Starnes, C., Lile, J., Scully, S., Guo, J., Elliott, G., McNinch, J., Shaklee, C.L., Freeman, D., Manu, F., Simonet, W.S., Boone, T. & Chang, M.S. (1999) Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family. Proceedings of the National Academy of Sciences of the United States of America, 96, 11458-11463.
29. Senaldi, G., Stolina, M., Guo, J., Faggioni, R., McCabe, S., Kaufman, S.A., Van, G., Xu, W., Fletcher, F.A., Boone, T., Chang, M., Sarmiento, U. & Cattley, R.C. (2002) Regulatory effects of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) on B cell function. Journal of Immunology, 168, 5690-5698.
30. Shi, Y., Wang, W., Yourey, P.A., Gohari, S., Zukauskas, D., Zhang, J., Ruben, S. & Alderson, R.F. (1999) Computational EST database analysis identifies a novel member of the neuropoietic cytokine family. Biochemical and Biophysical Research Communications, 262, 132-138.
31. Suematsu, S., Matsusaka, T., Matsuda, T., Ohno, S., Miyazaki, J., Yamamura, K., Hirano, T. & Kishimoto, T. (1992) Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 89, 232-235.
32. Uemura, A., Takizawa, T., Ochiai, W., Zanagisawa, M., Nakashima, K. & Taga, T. (2002) Cardiotrophin-like cytokine induces astrocyte differentiation of fetal neuroepithelial cells via activation of STAT3. Cytokine, 18, 1-7.
33. Westendorf, J.J. & Jelinek, D.F. (1996) Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression. Journal of Immunology, 157, 3081-3088.
34. Wijdenes, J., Heinrich, P.C., Müller-Newen, G., Roche, C., Gu, Z.J., Clement, C. & Klein, B. (1995) Interleukin-6 signal transducer gp130 has specific binding sites for different cytokines as determined by antagonistic and agonistic anti-gp130 monoclonal antibodies. European Journal of Immunology, 25, 3474-3481.
35. Zhang, X.G., Gu, J.J., Lu, Z.Y., Yasukawa, K., Yancopoulos, G.D., Turner, K., Shoyab, M., Taga, T., Kishimoto, T. & Bataille, R. (1994) Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130. Journal of Experimental Medicine, 179, 1337-1342.